PRESSURE BIOSCIENCES (PBIO)
PBIO moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How PBIO actually reacts to news — the realized, point-in-time move the market made, measured across 69 labeled events over the last three years with zero look-ahead.
PBIO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 35% | 49 |
| 30-min | 0.00% | 28% | 61 |
| 60-min | 0.00% | 30% | 64 |
| to close | 0.00% | 46% | 67 |
| Middle 50% of PBIO reactions | -5.19% to +0.60% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 69 |
Half of all PRESSURE BIOSCIENCES news events land between -5.19% and +0.60% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when PBIO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PBIO's baseline. Nothing else.
Recent PBIO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q PRESSURE BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q PRESSURE BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form 8-K PRESSURE BIOSCIENCES For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | — | -9.09% | |
| Form 8-K PRESSURE BIOSCIENCES For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | -12.70% | +2.19% | |
| Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray | Press release | GlobeNewswire | +0.00% | +4.54% | |
| Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET | Press release | GlobeNewswire | +0.00% | +3.57% | |
| Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET | Press release | GlobeNewswire | — | -3.44% | |
| Form 10-K PRESSURE BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -10.21% | -7.08% | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -0.42% | |
| Form 8-K PRESSURE BIOSCIENCES For: Apr 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Uncle Bud’s Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness | Press release | GlobeNewswire | — | +25.49% | |
| Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection” | Press release | GlobeNewswire | — | +17.65% | |
| Form NT 10-K PRESSURE BIOSCIENCES For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +17.65% | |
| Form DEF 14A PRESSURE BIOSCIENCES For: Feb 27 | SEC filing · Form DEF | SEC EDGAR | — | +0.29% | |
| Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc. | Press release | GlobeNewswire | +0.00% | -15.85% | |
| Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing | Press release | GlobeNewswire | +0.00% | -15.43% | |
| Uncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness | Press release | GlobeNewswire | +0.00% | -14.29% | |
| Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds | Press release | GlobeNewswire | +0.00% | +11.11% | |
| Form 8-K PRESSURE BIOSCIENCES For: Jan 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -6.30% | |
| Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales | Press release | GlobeNewswire | +14.31% | -9.50% | |
| Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order | Press release | GlobeNewswire | — | +2.56% | |
| Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January | Press release | GlobeNewswire | +0.95% | -9.52% | |
| Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets | Press release | Business Wire | +3.54% | -13.43% | |
| Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies | Press release | Accesswire | +0.00% | +4.40% | |
| Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform | Press release | Accesswire | — | +1.54% | |
| Pressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores | Press release | Accesswire | — | +12.12% | |
| Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador | Press release | Accesswire | -1.11% | +10.89% | |
| Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023 | Press release | Accesswire | -6.05% | -6.05% | |
| Form 10-Q PRESSURE BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -6.05% | -6.05% | |
| Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update | Press release | Accesswire | -8.50% | +0.00% | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +5.34% | +5.34% | |
| Peer-Reviewed Scientific Study Independently Confirms Pressure BioSciences’ UltraShear Nanoemulsion Platform Vastly Outperforms Current Technologies, Delivering CBD with Unprecedented Speed, Efficiency, Reliability, and Bioavailability | Press release | Accesswire | — | -7.69% | |
| Pressure BioSciences' Patented BaroFold Technology Platform for High Efficiency Biopharmaceuticals Manufacturing Featured at International Bioprocess Conference by Leading Global Contract Biologics Manufacturer | Press release | Accesswire | +2.61% | -2.52% | |
| Form 8-K PRESSURE BIOSCIENCES For: Oct 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.14% | |
| Pressure BioSciences Announces Exclusive Distribution Agreement with One of India’s Premier Distributors of Lab Automation, Instruments, and Consumables | Press release | Accesswire | — | +55.42% | |
| Pressure BioSciences Continues Expansion of IP Portfolio of Revolutionary UltraShear Technology with Award of First Canadian Patent | Press release | Accesswire | +0.00% | +0.00% | |
| Pressure BioSciences’ Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately | Press release | Accesswire | +2.56% | +2.56% | |
| Pressure BioSciences Fulfillment of UltraShear Nano-CBD Orders is Underway; Customer Shipments Begin First Week of October | Press release | Accesswire | — | +4.40% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PBIO section they belong to.
Where else PBIO is measured.
PBIO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares) (CCM) | 70 | 0.00% | 38% |
| AquaBounty Technologies, Inc. (AQB) | 69 | 0.00% | 49% |
| TOCAGEN INC COMMON (TOCA) | 69 | -0.59% | 39% |
| ASLAN Pharmaceuticals Limited - American Depositary Shares (ASLN) | 68 | -1.80% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is PRESSURE BIOSCIENCES's median reaction calculated?
Every labeled PBIO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 69 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 28% of PBIO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does PBIO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.